Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$1.51B |
| 2 |
iShares US Real Estate ETF
IYR
|
+$985M |
| 3 |
Apple
AAPL
|
+$890M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$774M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$736M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$673M |
| 2 |
Bank of America
BAC
|
+$615M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$515M |
| 4 |
NVIDIA
NVDA
|
+$451M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$417M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.95% |
| 2 | Financials | 8.18% |
| 3 | Consumer Discretionary | 7.81% |
| 4 | Healthcare | 7.12% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
StoneX
SNEX
$7.94B
| $3.51M | ﹤0.01% |
160,289
+98,213
| +158% | +$1.87M |
|
2377
Credo Technology Group
CRDO
$46.6B
| $3.5M | ﹤0.01% |
179,878
+142,318
| +379% | +$2.42M |
|
|
ECO
2378
Okeanis Eco Tankers
ECO
$2.42B
| $3.5M | ﹤0.01% |
+130,536
| New | +$3.46M |
|
|
ROVR
2379
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $3.49M | ﹤0.01% |
320,924
+257,990
| +410% | +$2.18M |
|
2380
Cable One
CABO
$212M
| $3.48M | ﹤0.01% |
6,259
-3,846
| -38% | -$2.2M |
|
2381
Acadia Realty Trust
AKR
$2.84B
| $3.48M | ﹤0.01% |
205,036
+121,309
| +145% | +$1.82M |
|
2382
ADT
ADT
$5.58B
| $3.48M | ﹤0.01% |
510,183
-90,846
| -15% | -$566K |
|
2383
Travere Therapeutics
TVTX
$5.78B
| $3.48M | ﹤0.01% |
386,809
+98,155
| +34% | +$715K |
|
2384
Dorman Products
DORM
$4.18B
| $3.46M | ﹤0.01% |
41,509
+28,303
| +214% | +$2.11M |
|
2385
National Vision
EYE
$1.81B
| $3.46M | ﹤0.01% |
165,380
+131,721
| +391% | +$2.34M |
|
|
NKLA
2386
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
| $3.46M | ﹤0.01% |
+131,880
| New | +$4.1M |
|
2387
Trinity Industries
TRN
$2.38B
| $3.46M | ﹤0.01% |
130,100
+87,259
| +204% | +$2.1M |
|
|
AIV
2388
Aimco
AIV
$383M
| $3.45M | ﹤0.01% |
441,040
+385,778
| +698% | +$2.6M |
|
2389
Agios Pharmaceuticals
AGIO
$1.93B
| $3.45M | ﹤0.01% |
154,736
+33,728
| +28% | +$756K |
|
2390
Live Oak Bancshares
LOB
$1.97B
| $3.45M | ﹤0.01% |
75,718
+75,668
| +151,336% | +$2.54M |
|
2391
Schneider National
SNDR
$6.25B
| $3.45M | ﹤0.01% |
135,367
+48,096
| +55% | +$1.19M |
|
2392
Skywest
SKYW
$4.34B
| $3.44M | ﹤0.01% |
65,973
+40,082
| +155% | +$1.8M |
|
2393
Arvinas
ARVN
$572M
| $3.44M | ﹤0.01% |
83,621
+49,824
| +147% | +$1.16M |
|
2394
CorVel
CRVL
$3.19B
| $3.44M | ﹤0.01% |
41,748
+28,719
| +220% | +$2.04M |
|
2395
Blink Charging
BLNK
$87.9M
| $3.43M | ﹤0.01% |
1,012,273
+934,112
| +1,195% | +$2.92M |
|
2396
Cerus
CERS
$474M
| $3.43M | ﹤0.01% |
1,588,070
+179,747
| +13% | +$296K |
|
2397
PUT
Texas Instruments
TXN
$261B
| $3.43M | ﹤0.01% |
20,100
-32,900
| -62% | -$5.1M |
|
2398
Pathward Financial
CASH
$1.8B
| $3.42M | ﹤0.01% |
64,705
+11,851
| +22% | +$582K |
|
|
PMT
2399
PennyMac Mortgage Investment
PMT
$842M
| $3.42M | ﹤0.01% |
229,039
+143,607
| +168% | +$1.93M |
|
|
ITOS
2400
DELISTED
iTeos Therapeutics
ITOS
| $3.42M | ﹤0.01% |
312,580
-9,742
| -3% | -$96.6K |
|
Similar funds
Barclays's Q4 2023 Portfolio in Review
As of Q4 2023, Barclays held 5,469 positions worth $273B, up 70% from $161B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays deployed $85.1B of net new capital in Q4 2023, opening 898 new positions and adding to 2,915 existing holdings. Its largest new stake was AngloGold Ashanti: 9,667,894 shares worth $181M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 27% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $673M trimmed.
- Barclays's largest Q4 2023 buy was AngloGold Ashanti: 9,667,894 shares worth $181M.
- Barclays added most to Meta Platforms (Facebook) in Q4 2023, an estimated $1.51B increase.
- Barclays's biggest Q4 2023 reduction was CRH, cutting an estimated $673M.
- Barclays fully exited Activision Blizzard in Q4 2023, selling an estimated $417M.
- Barclays's ten largest holdings make up 27% of its $273B portfolio in Q4 2023.
- Barclays opened 898 new positions and closed 253 in Q4 2023.
- Barclays's portfolio value rose 70% quarter-over-quarter to $273B.
Based on Barclays's 13F filing for Q4 2023, filed 15 Feb 2024.